
Based on FDA | Does warfarin cause erectile dysfunction?
There is no strong evidence that warfarin directly causes erectile dysfunction, and ED is not listed as a typical side effect in official labeling. Rare emergencies like priapism or penile tissue necrosis have been reported; most ED in people on warfarin is due to underlying cardiovascular risks, other medications, or psychological factors. Seek urgent care for a prolonged painful erection or sudden penile pain/discoloration.
Warfarin and erectile dysfunction: what we know There is no strong evidence that warfarin directly causes erectile dysfunction (ED) as a common or expected side effect. Most official prescribing information for warfarin does not list ED as an adverse effect, and large reviews focus on bleeding risks rather than sexual dysfunction. [1] [2] That said, a few rare, serious penile complications have been reported with anticoagulants, which are very different from typical ED and require urgent care. [3] [4]
Key takeaways
- ED is not recognized as a typical or frequent side effect of warfarin. [1] [2]
- Rare penile complications can occur with anticoagulants, including priapism (a prolonged, often painful erection) and even penile tissue necrosis in extreme situations; these are medical emergencies and not the same as common ED. [3] [5]
- If ED occurs while on warfarin, it is more likely related to underlying health conditions (heart disease, diabetes, vascular disease, depression), performance anxiety, or other medications, rather than a direct effect of warfarin itself. [1]
What official and clinical sources report
- Warfarin labeling emphasizes bleeding risks and very rare tissue necrosis; it does not list ED as a known adverse effect. [6] [7]
- The labeling notes that priapism has been associated with anticoagulant use, but a causal link has not been firmly established. [3] [8]
- Extremely rare reports describe penile necrosis or gangrene in specific high‑risk scenarios (e.g., early warfarin therapy in people with protein C deficiency or in settings like heparin‑induced thrombocytopenia). These are uncommon and present early after starting therapy. [9] [10]
How could anticoagulation affect sexual function indirectly?
- Underlying cardiovascular disease and its risk factors are leading causes of ED; many people who need warfarin also carry these risk factors, which likely explains most ED seen in this population. [1]
- Anxiety about bleeding or bruising may reduce sexual confidence, indirectly contributing to ED, though this is behavioral rather than a pharmacologic effect. [2]
- Rare emergencies (priapism) have been described with anticoagulants and can lead to long‑term erectile issues if not managed quickly, but this is exceptionally uncommon. [3] [4]
Red flags that are not typical ED
- Prolonged erection lasting more than 4 hours (priapism), especially if painful this needs emergency care to prevent tissue damage. [3]
- Sudden penile pain, discoloration, or skin changes early after starting warfarin seek immediate care, as tissue necrosis has been reported in rare cases. [7] [9]
Comparing warfarin to newer anticoagulants
Newer direct oral anticoagulants (DOACs) differ in dosing and monitoring but, like warfarin, do not have ED listed as a common side effect in clinical overviews; safety discussions focus on bleeding profiles rather than sexual dysfunction. [11] [12]
Practical guidance if you have ED while on warfarin
- Consider common contributors: blood pressure, diabetes, lipids, smoking, alcohol, sleep, stress, depression, and relationship factors addressing these often improves ED. [1]
- Review all medications with your clinician; some drugs (e.g., certain antidepressants, antihypertensives) can affect erections, and interactions with warfarin may limit options. [2]
- ED treatments can be compatible with warfarin, but some approaches (like penile injections) may increase local bleeding risk and need careful instruction. [13]
When to seek help
- New or worsening ED that affects quality of life discuss with your clinician to evaluate common causes and safe treatments. [1]
- Any erection lasting over 4 hours, or sudden penile pain/skin changes go to emergency care. [3] [7]
Summary table: Warfarin and sexual effects
-
Typical/expected side effect: Erectile dysfunction (ED)
-
Rare events: Priapism (prolonged erection)
- Evidence: Reported with anticoagulants; causality not established. [3]
-
Very rare, serious events: Penile tissue necrosis/gangrene
-
Likely main drivers of ED in people taking warfarin
If you’re experiencing erection difficulties while taking warfarin, it’s reasonable to evaluate common cardiovascular and lifestyle factors first and then consider ED treatments that are safe alongside anticoagulation, with your clinician’s guidance. [1] [2]
Related Questions
Sources
- 1.^abcdefghi[Bleeding complications in oral anticoagulant treatment].(pubmed.ncbi.nlm.nih.gov)
- 2.^abcdefgAre the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review.(pubmed.ncbi.nlm.nih.gov)
- 3.^abcdefgWarfarin Sodium Tablets, USP Crystalline(dailymed.nlm.nih.gov)
- 4.^abAnticoagulant-induced priapism progressing to penile gangrene: a devastating complication!(pubmed.ncbi.nlm.nih.gov)
- 5.^↑WARFARIN SODIUM(dailymed.nlm.nih.gov)
- 6.^↑WARFARIN SODIUM(dailymed.nlm.nih.gov)
- 7.^abcWARFARIN SODIUM(dailymed.nlm.nih.gov)
- 8.^↑Warfarin SodiumTablets, USPCrystalline(dailymed.nlm.nih.gov)
- 9.^abcWarfarin-induced penile necrosis in a patient with heparin-induced thrombocytopenia.(pubmed.ncbi.nlm.nih.gov)
- 10.^abWarfarin necrosis of the skin and subcutaneous tissue of the male external genitalia.(pubmed.ncbi.nlm.nih.gov)
- 11.^↑New oral anticoagulants: comparative pharmacology with vitamin K antagonists.(pubmed.ncbi.nlm.nih.gov)
- 12.^↑Advantages and limitations of the new anticoagulants.(pubmed.ncbi.nlm.nih.gov)
- 13.^↑These highlights do not include all the information needed to use CAVERJECT safely and effectively. See full prescribing information for CAVERJECT. CAVERJECT ® (alprostadil) for injection, for intracavernosal useInitial U.S. Approval: 1981(dailymed.nlm.nih.gov)
Important Notice: This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any medical decisions.


